P
PLRX
Pliant Therapeutics, Inc.
1.180
-0.030-2.48%Opening10:54 04/29 EDT
OPEN/PREV CLOSE1.200/1.210
TODAY RANGE1.180-1.210
VOL30.43K
MARKET CAP73.06M
52 WEEK RANGE1.090-1.950
AVG VOL (3M)625.89K
% TURNOVER0.05%
TURNOVER--
P/E (TTM)-0.4849
% RANGE2.48%
EPS(TTM)-2.4336
P/E(FORWARD)-0.7826
P/B0.4001
BVPS2.949
DIVIDEND--
P/S50.00
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP71.32M
SHARES OUTSTANDING61.91M
NEXT EARNINGS05/06-05/11
FREE FLOAT60.44M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·04/19 17:00
Pliant announces presentation of updated data from Phase 1 trial of PLN-101095
TipRanks·04/17 21:33
Pliant Therapeutics Announces Board Retirements and Option Repricing
TipRanks·03/30 22:54
Pliant Therapeutics Launches New $50 Million ATM Program
Benzinga·03/30 22:05
Pliant Therapeutics Files Prospectus To Offer Securities Up To $300M
TipRanks·03/30 22:05
Pliant Therapeutics files $300M mixed securities shelf
Reuters·03/30 21:59
PLIANT THERAPEUTICS INC - MAY OFFER SECURITIES UP TO $300 MLN - SEC FILING
Dow Jones·03/13 18:36
Pliant Therapeutics Price Target Cut to $3.00/Share From $4.00 by Canaccord Genuity
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.